Skip to main content

Singular Genomics Systems, Inc. (OMIC)

NASDAQ: OMIC · IEX Real-Time Price · USD
13.60 -0.08 (-0.58%)
Oct 22, 2021 3:39 PM EDT - Market open
Market Cap989.62M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out31.63M
EPS (ttm)-4.76
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume76,180
Open13.66
Previous Close13.68
Day's Range13.28 - 13.77
52-Week Range10.80 - 33.37
Betan/a
AnalystsBuy
Price Target27.67 (+103.5%)
Est. Earnings DateNov 3, 2021

About OMIC

Singular Genomics Systems is a life science technology company that is leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. We developed a unique and proprietary NGS technology, which we refer to as our Sequencing Engine. This Sequencing Engine is the foundational platform technology that forms the basis of our products in development and our core product tenets: accuracy, speed, flexibility and scale. We are currently developing two integrated solutions. The G4...

IndustryMedical Instruments & Supplies
IPO DateMay 27, 2021
CEOAndrew Spaventa
Employees169
Stock ExchangeNASDAQ
Ticker SymbolOMIC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for OMIC stock is "Buy." The 12-month stock price forecast is 27.67, which is an increase of 103.46% from the latest price.

Price Target
$27.67
(103.46% upside)
Analyst Consensus: Buy

News

Singular Genomics Systems, Inc. to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

LA JOLLA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced it ...

2 months ago - GlobeNewsWire

Singular Genomics Systems, Inc. Announces Second Quarter Financial Results and Operations Update

LA JOLLA, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today reported its ...

2 months ago - GlobeNewsWire

Singular Genomics Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Optio...

LA JOLLA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicin...

4 months ago - GlobeNewsWire

Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

LA JOLLA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine...

4 months ago - GlobeNewsWire

Sequencing Startup Singular Genomics Files for $100M IPO

The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.

5 months ago - GenomeWeb

Singular Genomics Systems IPO Registration Document (S-1)

Singular Genomics Systems, Inc. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC